NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 53 filers reported holding NEXTCURE INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -33.3% | 2 | -33.3% | 0.00% | – |
| Q1 2023 | $3 | -95.6% | 3 | -93.9% | 0.00% | – |
| Q4 2022 | $68 | -99.3% | 49 | -98.7% | 0.00% | – |
| Q3 2022 | $10,000 | -94.7% | 3,781 | -90.5% | 0.00% | – |
| Q2 2022 | $187,000 | +120.0% | 39,834 | +129.6% | 0.00% | – |
| Q1 2022 | $85,000 | -37.0% | 17,351 | -22.9% | 0.00% | – |
| Q4 2021 | $135,000 | -8.2% | 22,508 | +3.2% | 0.00% | – |
| Q3 2021 | $147,000 | -54.2% | 21,808 | -45.4% | 0.00% | – |
| Q2 2021 | $321,000 | -38.5% | 39,933 | -23.3% | 0.00% | – |
| Q1 2021 | $522,000 | -2.1% | 52,073 | +6.3% | 0.00% | – |
| Q4 2020 | $533,000 | +566.2% | 48,968 | +440.1% | 0.00% | – |
| Q3 2020 | $80,000 | -92.1% | 9,067 | -80.7% | 0.00% | – |
| Q2 2020 | $1,007,000 | -80.4% | 46,968 | -66.1% | 0.00% | -100.0% |
| Q1 2020 | $5,134,000 | +37.0% | 138,518 | +108.2% | 0.00% | 0.0% |
| Q4 2019 | $3,748,000 | +1053.2% | 66,545 | +531.4% | 0.00% | – |
| Q3 2019 | $325,000 | +2854.5% | 10,540 | +1276.0% | 0.00% | – |
| Q2 2019 | $11,000 | – | 766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |